BackAgios Pharmaceuticals Overview
Agios Pharmaceuticals Inc

Agios Pharmaceuticals Target Price

Where could AGIO trade next? Consensus target price: $47.

Get informed when a big investor buys or sells

+ Follow

Share Price

$33.55

Average Target Price

$46.8039.5% upside

5 analysts in the last 4 months

High: $55 | Low: $32

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30H.C. Wainwright$5563.9% upsideOpen
2026-07-21H.C. WainwrightEmily Bodnar$5255% upsideOpen
2026-07-07Truist Financial$4122.2% upsideOpen
2026-07-07RBC Capital$324.6% downsideOpen
2026-06-15H.C. WainwrightEmily Bodnar$5461% upsideOpen
2026-04-30Truist Financial$367.3% upsideOpen
2026-04-20H.C. WainwrightEmily Bodnar$5049% upsideOpen
2026-02-12Truist FinancialGreg Renza$3916.2% upsideOpen
2025-12-26Leerink Partners$4019.2% upsideOpen
2025-12-24H.C. Wainwright$6284.8% upsideOpen
2025-12-24Truist FinancialGregory Renza$3813.3% upsideOpen
2025-11-24Truist Financial$324.6% downsideOpen
2025-11-20Goldman Sachs$2525.5% downsideOpen
2025-11-20Leerink Partners$341.3% upsideOpen
2025-10-20H.C. WainwrightEmily Bodnar$5666.9% upsideOpen
2025-05-02ScotiabankGreg Harrison$71111.6% upsideOpen
2024-10-31Raymond JamesDanielle Brill$5152% upsideOpen
2024-09-27Leerink PartnersAndrew Berens$5666.9% upsideOpen
2024-09-10Raymond JamesChris Raymond$5666.9% upsideOpen
2024-06-17Raymond JamesChris Raymond$5563.9% upsideOpen
2024-06-03RBC CapitalGregory Renza$5358% upsideOpen
2024-05-28Raymond JamesChris Raymond$4534.1% upsideOpen
2023-02-03Piper Sandler$4122.2% upsideOpen
2022-12-01J.P. Morgan$331.6% downsideOpen
2022-11-17Goldman Sachs$324.6% downsideOpen
2021-04-30BarclaysPeter Lawson$70108.6% upsideOpen

Agios Pharmaceuticals (AGIO) FAQ

Agios Pharmaceuticals (AGIO) currently reports a target price of $47. Use the charts on this page to explore Agios Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for Agios Pharmaceuticals is $47, about 39.5% upside from the current share price of $33.55. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $47, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Agios Pharmaceuticals, and consider following AGIO for alerts when major investors trade the stock.

Agios Pharmaceuticals is classified in the Healthcare sector. On target price, it currently shows $47. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGIO with unrelated industries.